We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
This chapter proposes an ex ante approach to tackling drug scarcity. Entities funding pandemic- and epidemic-related research should contractually require recipients to produce sufficient quantities of resulting medicines. The recipient would agree in the event of a future shortage to share its technology and know-how with a qualified third-party manufacturer, in exchange for compensation. Alternatively, funding entities could more broadly utilize dormant licenses, which activate in the event of a pandemic or epidemic, and which require rights holders to license out technology and know-how to alleviate shortages. Such provisions could go even further, integrating reasonable pricing assurances and ensuring access in low-income countries. By tying funding to such rights, governments and nongovernmental organizations could help reduce shortages, improve global access to medicines, and ultimately save lives.
At the outset of the COVID-19 pandemic, numerous observers recognized the potential for patents and other intellectual property (IP) rights to hinder the development and dissemination of medical equipment and products responsive to the virus. Concerns over the impact of IP rights on pandemic response led to a range of national and international governmental interventions. Yet these concerns also spurred voluntary, private action by IP rights holders. This chapter discusses and assesses these private initiatives, with a focus on the Open Covid Pledge (OCP), an initiative that the author helped to organize. The OCP eventually led to the voluntary commitment of an estimated 500,000 patents to the COVID-19 response, was endorsed by Universities Allied for Essential Medicines (UAEM) and adopted by the WHO’s Covid Technology Access Pool (C-TAP) as a recommended mechanism for making technology available in the COVID-19 response.
This paper develops a monetary R&D-driven endogenous growth model featuring endogenous innovation scales and the price-marginal cost markup. To endogenize the step size of quality improvement, we propose a tradeoff mechanism between the risk of innovation failure and the benefit of innovation success in R&D firms. Several findings emerge from the analysis. First, a rise in the nominal interest rate decreases economic growth; however, its relationship with social welfare is ambiguous. Second, either strengthening patent protection or raising the professional knowledge of R&D firms leads to an ambiguous effect on economic growth. Third, the Friedman rule of a zero nominal interest rate fails to be optimal in view of the social welfare maximum. Finally, our numerical analysis indicates that the extent of patent protection and the level of an R&D firm’s professional knowledge play a crucial role in determining the optimal interest rate.
Economic tradecraft is a set of duties, responsibilities and skills required of diplomats working in economic affairs. It is a key instrument in the diplomatic tradecraft toolbox. As is the case with their colleagues in the political career track, economic officers work both at diplomatic missions abroad and at headquarters. On the surface, it may appear that a country’s economic and commercial diplomats do the same type of work abroad, but that is not quite the case. Economic officers inform policymaking at headquarters by monitoring and analyzing economic trends and developments in the receiving state. They also advocate for host-government policies aimed at leveling the playing field for companies from the home country and against regulations that hurt those businesses. Commercial diplomats directly help industries and individual companies in starting or expanding business and investment in the host country. Conversely, they facilitate investment by local firms in the home country.
For latecomer countries, one crucial decision is whether to follow the path of economic development traveled by rich countries or to seek out new trajectories. This book observes that latecomers do not always follow advanced countries’ paths; rather, they sometimes skip certain stages and even create their own paths by taking detours and pursuing leapfrogging. The need for detours arises due to the entry barriers, such as intellectual property rights restrictions, protectionist measures, and limited policy spaces under WTO. This book proposes an alternative to prevailing development thinking by focusing on nonlinearity and the multiplicity of pathways for latecomers. The book leaves several questions for future research, such as the rules and modus operandi of the government, and importance of initial conditions. Also, the political and economic power balance between global institutions and national actors determines the dynamics of global–local interfaces. This book does not engage much with the issue of sustainable development, but seeking alternative economic development strategies that produce fewer carbon emissions is consistent with the idea of nonlinearity and the multiplicity of developmental trajectories.
The global impacts of COVID-19 have been calamitous, unleashing widespread human suffering and exacerbating health crises, all while worsening pre-existing inequalities and transgressing fundamental human rights. Despite earnest pleas from the United Nations and developing nations for an equitable distribution of COVID-19 vaccines, these appeals were largely unheeded. Instead, major pharmaceutical manufacturers and high-income countries (HICs) had maintained a stranglehold on vaccine technology through the safeguarding of intellectual property rights (IPRs), leading to exorbitant pricing and preferential distribution to affluent regions. This vaccine hoarding has left low- and middle-income countries (LMICs) with delayed and insufficient supplies, endangering the lives of the most vulnerable. The stringent enforcement of IPRs mechanisms, rather than aligning with international human rights obligations, has further marginalised the right to life, health, and access to vaccines and medicines, particularly in LMICs. This study ardently advocates for a policy shift that promotes the decolonisation of human rights in the context of IPRs and global health law.
This chapter applies Pragmatic Constructivism to assess communities of practice in global health governance. It focuses on the problem of containing contagious diseases. This is one of the tasks of the World Health Organization (WHO) and its practice of declaring a Public Health Emergency of International Concern (PHEIC). Given the uncertainty surrounding such a practice, which could lead to the isolation of an effected state, the decision inevitably involves judgement calls rather than the pre-reflexive implementation of pre-planned steps. Applying the first Pragmatic Constructivist test to this practice means asking if the community of practice charged with making that judgement is properly constituted and sufficiently inclusive. The evidence suggests that it is not. The chapter problematizes practice that unduly privileges technical (in this case epidemiological) expertise over social and political advice. A second application of the two Pragmatic Constructivist tests focuses on an inconsistency internal to global health practices as they relate to the distribution of vaccines. Practices that achieve more comprehensive coverage, such as the local manufacture of vaccines, are being prevented by intellectual property practices. The chapter considers how the knowledge of the Covid pandemic challenges the epistemic authority of intellectual property practices.
This article uses data from several publicly available databases to show that the distribution of intellectual property for frontier technologies, including those useful for sustainable development, is very highly skewed in favor of a handful of developed countries. The intellectual property rights (IPR) regime as it exists does not optimize the global flow of technology and know-how for the attainment of the sustainable development goals and is in need of updating. Some features of the Fourth Industrial Revolution imply that the current system of patents is even more in need of reform than before. COVID-19 vaccines and therapies and the vast inequality in access to these has highlighted the costs of inaction. We recommend several policy changes for the international IPR regime. Broadly, these fall into three categories: allowing greater flexibility for developing countries, reassessing the appropriateness of patents for technologies that may be considered public goods, and closing loopholes that allow for unreasonable intellectual property protections.
Generally, the political consensus at the beginning of the internet era was that platforms should have only limited liability under intellectual property law for content that users uploaded on these platforms.1 Now, however, the platforms are the center of gravity for the Internet, drawing in (for technical reasons and owing to network effects) all data streams in the respective ecosystems, for the benefit of the system leader controlling the platform. Furthermore, the contracts that system leaders conclude with business users, and which control their business relationship, not only normally grant the exclusive right to data generated on the platform to the platform provider but also generally neutralize any intellectual property rights held by the business user. Indeed, the system leaders are regulators of their respective ecosystems and use their system of contracts to control the ecosystems and exclude the use and importance of intellectual property rights. The platform or cloud provider contractually secures the right from the platform or cloud user, not only to store the data but also to analyze it and make use of it for the provider’s own benefit, and for the benefit of others in the ecosystem, on all connected markets. The platform providers thus become the masters of their respective data ecosystems; they do indeed hoard the data and generally do not trade or share the data.
This article critically examines the proposed waiver of intellectual property (IP) rights for COVID-19 vaccines under the World Trade Organization Agreement's Trade-Related Aspects of Intellectual Property Rights (TRIPS), which was initiated in October 2020 when the pandemic raged and vaccines were unavailable. However, the landscape has now changed and the waiver may no longer be necessary. The Outcome Document, introduced in the TRIPS Council in May 2022, along with Ministerial Decision of June 2022 recognizes this by focusing on easing the requirements to use TRIPS-flexibilities to accomplish wider and cheaper access. In so doing, the Ministerial Decision reinforces the notion that TRIPS flexibilities can be a useful part of the policy toolkit, even in times of crisis. After providing an overview of the context and outlining justifications for the waiver proposal, the article analyses and identifies key implications and possible effects of the Ministerial Decision. The article concludes that while the Document may not be a perfect solution to the issue of access to vaccines, flexible application of TRIPS-flexibilities is a better resolution in the current environment, especially given the need for further innovation to combat COVID-19 and future pandemics.
Open innovation programmes related to data and artificial intelligence have interested European policy-makers as a means of supporting startups and small and medium-sized enterprises to succeed in the digital economy. We discuss the objectives behind the typical service offerings of such programmes and propose a case for exploring how they align with the motivations of individual companies who are targeted by these initiatives. Using a qualitative analysis of 50 startup applications from the Data Market Services Accelerator programme, we find that applicants wrote most frequently about fundraising, acceleration and data skills. A smaller number of startups expressed interest in services related to standardization or legal guidance on General Data Protection Regulation and intellectual property rights, which are some of the ongoing priority areas for the European Commission. We discuss how the value propositions of these less desired offerings can be amplified by appealing the existing business motivations of data-driven startups.
This chapter explores the theme of innovation and IP use in the mining industry by providing a foreign direct investment (FDI) angle. It highlights the role of mining multinational enterprises (MNEs), both as main actors of international production and in their links with host countries’ government and social and economic context. The development implications of FDI spillovers seem critical in the mining industry where the bulk of investment takes place in developing countries, often the least developed countries. The chapter describes the mining FDI ecosystem: key MNE players, recent trends and outlook and investment policy directions. It discusses the different types of impacts that mining FDI can have on host countries, with a particular view towards poor and vulnerable economies.
This chapter is structured into three main sections. Section 4.2 provides a brief overview of the legal framework on pharmaceutical patent law in Kenya. Section 4.3 deals with the key issue in this chapter, that is, the incorporation of a model of human rights into the adjudication of disputes involving pharmaceutical patent rights by courts in Kenya. Section 4.4 examines whether, in the light of Article 40(5) of the Kenyan Constitution which provides that the state ‘shall support, promote and protect the intellectual property rights of the people of Kenya’, intellectual property rights can be considered as a human right in Kenya. The chapter concludes with the view that it is essential for courts seeking to protect the right of poor patients to have access to affordable medicines to incorporate a model of human rights when they adjudicate disputes involving pharmaceutical patent rights.
This chapter discusses how culture affects economic development. Based on historical, political, and economic reasons, China today has a strongly pro-economic growth culture. Historically, the Confucian culture of frugality, hard-working, and respecting the family is conducive to economic productivity. Politically, the authoritarian political system has shaped a population that is relatively more obedient and deferent to authority – traits that contribute to efficiency for low-skilled work such as manufactu¬ring. Economically, decades of poverty under Mao’s rule made people extremely motivated to work hard to make money. All these factors fueled China’s high economic growth. The chapter also draws attention to the fact that Mao had left an indelible imprint on today’s business leaders in China, a unique and important phenomenon that the international business community should be aware of. It also shows that a “Mao plus Deng” effect – Mao’s lawlessness and Deng’s call to get rich – is the root cause of property rights violations and especially the persistent problems of product safety and counterfeit goods in China.
This article is a critical legal analysis of the proposed TRIPS waiver under World Trade Organization (WTO) law. It reviews the existing TRIPS flexibilities and the “August 2003 TRIPS waiver”, highlighting the obstacles to achieving the goals of these legal instruments. It demonstrates that numerous critical TRIPS flexibilities, notably TRIPS Article 31bis, are ineffective, prompting some countries to submit a new waiver proposal to the WTO. It highlights several WTO rules that are also quite ambiguous. This paper argues that a WTO clarification might be an alternative to the new TRIPS waiver proposal if it is ultimately rejected due to a lack of consensus among WTO members. Finally, this article emphasises the importance of adopting a balanced approach that may simplify complicated TRIPS rules, decrease the risk of trade-based retaliation and improve collaboration in knowledge transfer and scaling up the manufacture of and access to lifesaving vaccines, pharmaceuticals and healthcare equipment.
How has America’s political economy changed from the long post-war “Fordist” era to the contemporary post-Fordist or knowledge economy? How has this shift affected economic growth and inequality of income and regions? Most analyses focus on specific aspects, like aggregate income inequality, or the rise of a shareholder value model for corporate governance, or increased trade competition (aka globalization), or the financial sector’s disproportionate power and profitability (aka financialization).
The Trump administration’s multi-front trade war dramatically escalated with the imposition of extraordinary tariffs on Chinese imports in 2018. Corporate America has responded with a concerted campaign of resistance. We document these efforts – through extensive participation in notice and comment and public coalition-building – and show that corporate opposition to the trade war is primarily a consequence of firms' sourcing and production linkages with China. In contrast, we find far weaker efforts by anti-trade firms to support the trade war, whether to insulate themselves from import competition or to confront Chinese trade practices. We therefore describe and empirically illustrate the politics of global production networks, and highlight that scholars of trade politics should not neglect opposition to the Trump trade agenda arising from globally integrated firms. Global order in the area of trade hangs in the balance in an ongoing fight between corporate globalism and populist nationalism.
In Jessup’s 1956 Storrs Lecture he defined transnational law as “all law which regulates actions or events that transcend national frontiers,” which includes public international law, private international law, and “other rules which do not wholly fit into such standard categories.” Considerable recent scholarship on transnational law has focused on that residual category of “other rules” and their “private” character. There has, however, been a revolution in international law itself since 1956, reflected in a proliferation of international institutions, international courts, treaties, and so-called “soft law” technologies of governance. This chapter assesses the role of international law in the creation of what can be viewed as “transnational legal orders” that penetrate and imbue state law, shape social identity, and inform public and private legal practice. International law, this chapter contends, is even a more important shaper of the transnational than in Jessup’s time, and, in turn is shaped by it.
This chapter focuses on the contributions of economists to the selection, design, and evaluation of language policies, particularly since the late 1970s. We show how to perform status analysis using available data on earnings, language skills, language of work, and language of consumption. Then, we turn to the evaluation of the costs and benefits of language policy measures. We add a section on the use of stylized data, an approach common in economic theoretical modeling and empirical evaluation. Finally, this chapter discusses some challenges in understanding the role of economic processes in language issues.
This study uses an econometric approach to investigate the role of IPR protection on renewable energy adoption using panel data of 102 countries at five-year intervals over the period 1990–2005. The Ginarte-Park index is used as a measure of the strength of intellectual property protection while the adoption of renewable energy is measured by the share of renewable energy in total final energy use. The results reveal that the level of intellectual property rights protection and reform of the intellectual property rights regime do not have significant impact on renewable energy adoption, suggesting that IPR protection is not a cause for concern in the global quest for clean energy transition. On the contrary, we find that trade openness has a stronger influence in the transition to clean energy. Based on the findings of the study, we conclude that IPR protection does not influence renewable energy adoption except in high R&D countries; rather policy makers should concentrate efforts on economic factors, such as trade openness, that drive the adoption of renewable energy technologies.